Sildenafil Tablet, Film Coated
Product Images NDC 63187-619

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 63187-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-619-90 (20mg90s)

This is a description of Sildenafil 20mg tablets that are packaged by Proficient Rx LP. The tablets are white to off white colored, round shaped, biconvex, and film-coated. Each tablet contains sildenafil citrate, USP, equivalent to 20mg of sildenafil. The tablets are debossed with "Sildenafil 20mg" on one side and "95" on the other side. The tablets are available in a package of 20 tablets and meant for Rx only. The product should be stored at 20°-25°C, and kept out of the reach of children. The product is manufactured by Hetero Labs Limited, located in India.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This is a table providing recommendations for drug interactions and fold change for certain medications. Specifically, it includes information on the need for dose adjustments for the drugs Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. The table also includes a graph showing the change relative to Sildenafil alone for a particular medication. 95% confidence intervals are provided for some of the data.*

FDA Label Image

Figure3 (Figure3)

This text appears to be a report or a list of drugs that interact with Acenocoumarol. The list includes various drugs such as Aspirin, Atorvastatin, Bosentan and more. The report lists the impact of these drugs on various parameters such as INR, AUC, Cmax, etc. Based on this data, the report gives recommendations on dose adjustment or states that co-administration is not recommended. The text may be useful for medical professionals dealing with patients who are taking Acenocoumarol and need to avoid drug interactions.*

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Structure (Structure)

FDA Label Image

Address1 (Address1)

FDA Label Image

Address2 (Address2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.